1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMRFF – 2025 Cardiovascular Health Grant Opportunity (GO7554) is sponsored by NHMRC. Supports medical research and innovation projects targeting cardiovascular disease and stroke, including preventive interventions and clinical trials.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
MRFF 2025 Cardiovascular Health - Research support - University of Queensland MRFF 2025 Cardiovascular Health Medical Research Future Fund The 2025 round is closed. Applications are under assessment and outcomes are anticipated in December 2025.
Proposals open in Sapphire: 12 February 2025 UQ R&I NOI Close: 16 July 2025 Minimum data requirements in Sapphire: 5pm ACT time 16 July 2025 Applications due to UQ R&I: 23 July 2025 Applications close: 5pm ACT time 13 August 2025 (Please note the UQ Research office will be closed on 13 August 2025 for EKKA Public Holiday.
All applications must be submitted by the 12 August 2025) MRFF Information Webinar “From research to translation: Cardiovascular Health Mission”: 19 June 2025. Link to register . Consistent with the MRFF Act, the objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: Stream 1 (Priority Area 1.
2; Targeted Call for Research): reduce the number of Australians experiencing cardiovascular disease and stroke by developing and implementing early, more effective preventive health interventions, by co-designing and developing strategies with Aboriginal and/or Torres Strait Islander people to embed best-practice, culturally secure cardiovascular disease and stroke prevention for Aboriginal and/or Torres Strait Islander people into care.
Stream 2 (Priority Area 2. 2; Targeted Call for Research): conduct Phase 1 and Phase 2 clinical trials to demonstrate safety and potential efficacy of novel devices and therapeutic approaches for cardiovascular disease and stroke. Steam 3 (Priority Area 3.
2; Targeted Call for Research): conduct a large-scale multiomics project focused on improving understanding of recovery trajectories and phenotypes, underpinning recovery and survivorship in cardiovascular disease and stroke. Stream 4 (Priority Area 1.
2; Targeted Call for Research): reduce the number of Australians experiencing cardiovascular disease and stroke by developing and implementing early, more effective preventive health interventions.
T opic A : developing and implementing novel therapeutics/technologies for the prevention of cardiac disease caused by chronic diseases Topic B : developing and implementing novel discoveries and markers to improve risk prediction Topic C : developing and implementing novel approaches to tailor preventive care, support adherence and reduce inequalities This grant opportunity is intended to support projects that progress research that addresses a specific health need.
For Stream 2, applications that propose to conduct a phase I trial, a phase II trial or a combined phase I/II trial are acceptable. A person must not be named as a Chief Investigator (CI) on more than one application submitted to this grant opportunity. Stream 1 : There is no minimum grant amount and the maximum amount available for a single grant is $2.
0 million. Stream 2 : There is no minimum grant amount and the maximum amount available for a single grant is $3. 0 million.
Stream 3 : The minimum amount available for a single grant is $3. 0 million and the maximum amount available for a single grant is $5. 0 million.
Stream 4 : There is no minimum grant amount and the maximum amount available for a single grant is $3. 0 million. Internal notice of intent process All researchers intending to submit an MRFF application are required to submit a mandatory internal Notice of Intent.
NOIs will be collated centrally and distributed to Faculties and Institutes in order to provide maximum support to the UQ research community. Step 1. Sapphire updates and scheme reading Register for Sapphire and update your full profile 'My Profile and CV'.
The Grant Opportunity will be run through the new National Health and Medical Research Council (NHMRC) grants management system, Sapphire, which replaces RGMS. If any team members are new to Sapphire and need a login/password, start early. The NHMRC require at least three working days to create new Sapphire accounts.
Familiarise yourself with the key MRFF, NHMRC and The University of Queensland (UQ) documentation. Step 2. Completing the application Step 3.
UQ R&I internal review and feedback Ahead of internal review, ensure all online components are complete and valid in Sapphire and CIA has initiated the Certification process. Application errors will be signalled and can be corrected during the Certification stage. To initiate internal review, email your completed Funding Application Certification to UQ R&I at mrffgrants@research.
uq. edu. au .
Internal review by UQ R&I/feedback provided (compliance/eligibility/grantsmanship). Final submission by UQ R&I to NHMRC. Signing for all letters of support from UQ is co-ordinated through the Research Office.
All Letters of support for MRFF applications, including those led by other institutions, must be accompanied by a completed Funding Application Certification (see below) and authorisations of any enumerated contributions or additional UQ staff beyond the lead CI listed in the letter. We strongly recommend working with your local school/institute research professionals to complete this process.
To provide time for review and signature, we ask that UQ researchers submit draft letters to mrffgrants@research. uq. edu.
au no later than two weeks before the external closing date. We would encourage applicants to provide drafts of partner letters of support for review by the Research office before organising their final signature to ensure eligibility and compliance. A template Letter of Support is provided below.
The administering organisation should provide you with a draft letter of support. UQ information from the CEO letter below may assist you in completing the letter. Complete a generic Funding Application Certification , and get it countersigned by your Head of School/Institute.
Submit both to mrffgrants@research. uq. edu.
au , along with evidence for any additional co-contributions. Readership and researcher support Before applying, we recommend you: Familiarise yourself with the framework for Applying for Competitive Research Grants at UQ. Contact your faculty or institute research manager for advice on peer readership programs.
Access the UQ R&I Grants Library , a helpful resource of past successful proposals.
Read the UQ R&I Grant writing advice and strategy website for tips on preparing your application Before applying, please review the full suite of documents available from GrantConnect, the Australian Government grants information system and: MRFF Monitoring, Evaluation and Learning Strategy 2020-21 to 2023-24 NHMRC Research Classification Guides UQ MRFF Application Certification Form (DOCX, 70.
5 KB) *updated 29 Apr 2025 UQ MRFF Declaration of Interests (DOCX, 21. 9 KB) UQ MRFF Letter of Support template (DOCX, 38.
3 KB) UQ How to Guide for MRFF Grants (PDF, 417 KB) MRFF 2026 Consumer-Led Research MRFF 2026 Early to Mid-Career Researchers MRFF 2026 Genomics Health Futures MRFF 2026 Indigenous Health Research - Empowering Community-Controlled Research MRFF 2026 International Clinical Trial Collaborations MRFF 2026 Mental Health Research MRFF 2026 National Critical Research Infrastructure MRFF 2026 Post-Acute Sequelae of COVID-19 MRFF 2026 Traumatic Brain Injury MRFF 2025 Clinical Trials Activity MRFF 2025 Genomics Health Futures MRFF 2025 Research Data Infrastructure MRFF 2025 Cardiovascular Health MRFF 2025 Dementia, Ageing and Aged Care MRFF 2025 Stem Cell Therapies MRFF 2025 Brain Cancer Research MRFF 2025 Cardiovascular Disease and Diabetes Models of Care MRFF 2025 Cardiovascular Disease and Diabetes Risk Prediction and Data Solutions MRFF 2025 International Clinical Trial Collaborations MRFF 2025 Childhood Mental Health Research MRFF Frontier Health and Medical Research Program MRFF 2025 Early to Mid-Career Researchers MRFF 2025 Mental Health and Climate Change MRFF 2024 Clinical Trial Enabling Infrastructure MRFF 2024 National Critical Research Infrastructure MRFF 2024 Rapid Applied Research Translation Scheme and Sapphire queries mrffgrants@research.
uq. edu. au
According to the current listing, eligibility includes: Researchers and institutions conducting relevant medical research. Confirm the full requirements in the official notice before applying.
MRFF – 2025 Cardiovascular Health Grant Opportunity (GO7554) is funded by NHMRC. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.